Abnormal Tc99m sulesomab in Klippel-Trenaunay syndrome

Shabina Begum; Ewa Nowosinska; John R. Buscombe

Vol 13, No 2 (2010)

Case report

Submitted: 2012-01-23

Published online: 2011-05-20

View PDF

Download PDF file

Get Citation

Abnormal Tc99m sulesomab in Klippel-Trenaunay syndrome

Shabina Begum, Ewa Nowosinska, John R. Buscombe

Nucl. Med. Rev 2010;13(2):84-86.

Vol 13, No 2 (2010)

Case Report

Submitted: 2012-01-23

Published online: 2011-05-20

Abstract

Tc-99m sulesomab is indicated in bone and joint infection, but reading of scans can be affected by pre-existing conditions. This case report describes a case of Klippel-Trenaunay syndrome (KTS) which results in vascular malformations of one or more limbs. Tc-99m sulesomab imaging demonstrated persistent blood pool activity up to 20 hours post injection. However, despite this, septic arthritis could be identified with confidence in the same limb.
Nuclear Med Rev 2010; 13, 2: 84–86